Welcome to LookChem.com Sign In|Join Free
  • or
Tert-Butyl 2-(aMinoMethyl)azetidine-1-carboxylate is a versatile chemical compound featuring an azetidine ring with a tert-butyl group and an aminomethyl group attached to it. It is widely recognized for its role in organic synthesis and pharmaceutical research, where it serves as a valuable building block for the creation of new molecules with potential biological activity. The tert-butyl group imparts steric hindrance, enhancing the compound's stability and reducing its reactivity, while the aminomethyl group is capable of engaging in a range of chemical reactions, including nucleophilic substitution and reductive amination. tert-Butyl 2-(aMinoMethyl)azetidine-1-carboxylate's diverse reactivity and potential pharmacological properties make it a promising candidate for the development of innovative drugs and materials.

939760-37-9

Post Buying Request

939760-37-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

939760-37-9 Usage

Uses

Used in Pharmaceutical Research:
Tert-Butyl 2-(aMinoMethyl)azetidine-1-carboxylate is used as a building block in pharmaceutical research for the development of new drugs. Its unique structure and reactivity allow for the creation of molecules with potential therapeutic applications, contributing to the advancement of medicine.
Used in Organic Synthesis:
In the field of organic synthesis, Tert-Butyl 2-(aMinoMethyl)azetidine-1-carboxylate is employed as a key intermediate. Its ability to participate in various chemical reactions, such as nucleophilic substitution and reductive amination, makes it a valuable component in the synthesis of complex organic molecules.
Used in Drug Development:
Tert-Butyl 2-(aMinoMethyl)azetidine-1-carboxylate is utilized in drug development as a precursor for the synthesis of pharmaceutical compounds. Its versatile reactivity and potential pharmacological properties enable the creation of new drugs with improved efficacy and reduced side effects.
Used in Material Science:
In material science, Tert-Butyl 2-(aMinoMethyl)azetidine-1-carboxylate is used as a component in the development of new materials. Its unique structure and properties can contribute to the creation of innovative materials with enhanced performance characteristics.
Used in Chemical Research:
Tert-Butyl 2-(aMinoMethyl)azetidine-1-carboxylate is employed in chemical research as a model compound for studying various chemical reactions and mechanisms. Its reactivity and structural features provide valuable insights into the behavior of similar compounds and contribute to the understanding of fundamental chemical processes.

Check Digit Verification of cas no

The CAS Registry Mumber 939760-37-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,9,7,6 and 0 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 939760-37:
(8*9)+(7*3)+(6*9)+(5*7)+(4*6)+(3*0)+(2*3)+(1*7)=219
219 % 10 = 9
So 939760-37-9 is a valid CAS Registry Number.

939760-37-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-Butyl 2-(aminomethyl)azetidine-1-carboxylate

1.2 Other means of identification

Product number -
Other names 1-Boc-2-azetidinemethanamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:939760-37-9 SDS

939760-37-9Downstream Products

939760-37-9Relevant academic research and scientific papers

AZETIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS

-

Page/Page column 24, (2010/09/07)

The invention relates to novel azetidine compounds of formula (I), wherein R1, R2, and X are as described in the description and their use as orexin receptor antagonists.

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

-

, (2008/06/13)

Chemical entities that modulate smooth muscle myosin and/or non-muscle myosin, and chemical entities, pharmaceutical compositions and methods of treatment of diseases and conditions associated with smooth muscle myosin and/or non-muscle myosin are described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 939760-37-9